COMMUNICATION
|
doi:10.20944/preprints202212.0131.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
rasburicase; anaphylaxis; re-administration; hematological malignancies; claims data
Online: 7 December 2022 (11:54:18 CET)
CASE REPORT
|
doi:10.20944/preprints202207.0304.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
PCNSL; high-dose methotrexate; acute uric acid nephropathy; rasburicase
Online: 20 July 2022 (11:52:03 CEST)
ARTICLE
|
doi:10.20944/preprints202405.0962.v1
Subject:
Oncology And Oncogenics,
Medicine And Pharmacology
Keywords:
Rasburicase; Tumor Lysis syndrome; Cost-effectiveness; 3 mg single fixed dose
Online: 14 May 2024 (12:46:34 CEST)